Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer.
Scrima M, De Marco C, De Vita F, Fabiani F, Franco R, Pirozzi G, Rocco G, Malanga D, Viglietto G.
Am J Pathol. 2012 Mar;180(3):1202-14. Epub 2012 Jan 13.
Related citations
Sec62 bridges the gap from 3q amplification to molecular cell biology in non-small cell lung cancer.
Linxweiler M, Linxweiler J, Barth M, Benedix J, Jung V, Kim YJ, Bohle RM, Zimmermann R, Greiner M.
Am J Pathol. 2012 Feb;180(2):473-83. Epub 2011 Dec 21.
Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment.
Bourboulia D, Jensen-Taubman S, Rittler MR, Han HY, Chatterjee T, Wei B, Stetler-Stevenson WG.
Am J Pathol. 2011 Nov;179(5):2589-600. Epub 2011 Sep 18.
Signal transducer and activator of transcription 3 (Stat3C) promotes myeloid-derived suppressor cell expansion and immune suppression during lung tumorigenesis.
Wu L, Du H, Li Y, Qu P, Yan C.
Am J Pathol. 2011 Oct;179(4):2131-41. Epub 2011 Aug 22.
Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.
Cisowski J, O'Callaghan K, Kuliopulos A, Yang J, Nguyen N, Deng Q, Yang E, Fogel M, Tressel S, Foley C, Agarwal A, Hunt SW 3rd, McMurry T, Brinckerhoff L, Covic L.
Am J Pathol. 2011 Jul;179(1):513-23. Epub 2011 May 7.
Lung-residing metastatic and dormant neuroblastoma cells.
Edry Botzer L, Maman S, Sagi-Assif O, Meshel T, Nevo I, Bäuerle T, Yron I, Witz IP.
Am J Pathol. 2011 Jul;179(1):524-36. Epub 2011 May 3.
Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition.
Martin P, Liu YN, Pierce R, Abou-Kheir W, Casey O, Seng V, Camacho D, Simpson RM, Kelly K.
Am J Pathol. 2011 Jul;179(1):422-35. Epub 2011 May 13.
Standardization of epidermal growth factor receptor (EGFR) measurement by quantitative immunofluorescence and impact on antibody-based mutation detection in non-small cell lung cancer.
Dimou A, Agarwal S, Anagnostou V, Viray H, Christensen S, Gould Rothberg B, Zolota V, Syrigos K, Rimm DL.
Am J Pathol. 2011 Aug;179(2):580-9. Epub 2011 Jun 12.
Importance of molecular features of non-small cell lung cancer for choice of treatment.
Moran C.
Am J Pathol. 2011 May;178(5):1940-8. Review.
Circulating tumor cells as a window on metastasis biology in lung cancer.
Hou JM, Krebs M, Ward T, Sloane R, Priest L, Hughes A, Clack G, Ranson M, Blackhall F, Dive C.
Am J Pathol. 2011 Mar;178(3):989-96.
Role of cholesterol in the development and progression of breast cancer.
Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, Sotgia F, Lisanti MP, Frank PG.
Am J Pathol. 2011 Jan;178(1):402-12. Epub 2010 Dec 23.
ERCC1 and RRM1 in the international adjuvant lung trial by automated quantitative in situ analysis.
Bepler G, Olaussen KA, Vataire AL, Soria JC, Zheng Z, Dunant A, Pignon JP, Schell MJ, Fouret P, Pirker R, Filipits M, Brambilla E.
Am J Pathol. 2011 Jan;178(1):69-78. Epub 2010 Dec 23.
A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer.
Llaverias G, Danilo C, Wang Y, Witkiewicz AK, Daumer K, Lisanti MP, Frank PG.
Am J Pathol. 2010 Dec;177(6):3180-91. Epub 2010 Nov 18. Erratum in: Am J Pathol. 2011 Mar;178(3):1406.
Co-activation of epidermal growth factor receptor and c-MET defines a distinct subset of lung adenocarcinomas.
Matsubara D, Ishikawa S, Sachiko O, Aburatani H, Fukayama M, Niki T.
Am J Pathol. 2010 Nov;177(5):2191-204. Epub 2010 Oct 7.
Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.
Amodio N, Scrima M, Palaia L, Salman AN, Quintiero A, Franco R, Botti G, Pirozzi P, Rocco G, De Rosa N, Viglietto G.
Am J Pathol. 2010 Nov;177(5):2622-34. Epub 2010 Oct 1.
Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development.
Zhou F, Chang Z, Zhang L, Hong YK, Shen B, Wang B, Zhang F, Lu G, Tvorogov D, Alitalo K, Hemmings BA, Yang Z, He Y.
Am J Pathol. 2010 Oct;177(4):2124-33. Epub 2010 Aug 19.
PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.
Esteva FJ, Guo H, Zhang S, Santa-Maria C, Stone S, Lanchbury JS, Sahin AA, Hortobagyi GN, Yu D.
Am J Pathol. 2010 Oct;177(4):1647-56. Epub 2010 Sep 2.
Morphine suppresses tumor angiogenesis through a HIF-1alpha/p38MAPK pathway.
Koodie L, Ramakrishnan S, Roy S.
Am J Pathol. 2010 Aug;177(2):984-97. Epub 2010 Jul 8.
Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells.
Demers M, Rose AA, Grosset AA, Biron-Pain K, Gaboury L, Siegel PM, St-Pierre Y.
Am J Pathol. 2010 Jun;176(6):3023-31. Epub 2010 Apr 9.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on